BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19854463)

  • 1. Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments.
    MacLeod SL; Wong CS
    Water Res; 2010 Jan; 44(2):533-44. PubMed ID: 19854463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
    Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska.
    Bartelt-Hunt SL; Snow DD; Damon T; Shockley J; Hoagland K
    Environ Pollut; 2009 Mar; 157(3):786-91. PubMed ID: 19110357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of a model to estimate wastewater treatment plant prescription pharmaceutical influent loadings and concentrations.
    Ottmar KJ; Colosi LM; Smith JA
    Bull Environ Contam Toxicol; 2010 May; 84(5):507-12. PubMed ID: 20411240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of selected pharmaceuticals, personal care products and artificial sweetener in an aerated sewage lagoon.
    Hoque ME; Cloutier F; Arcieri C; McInnes M; Sultana T; Murray C; Vanrolleghem PA; Metcalfe CD
    Sci Total Environ; 2014 Jul; 487():801-12. PubMed ID: 24393598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogenous photocatalytic degradation kinetics and detoxification of an urban wastewater treatment plant effluent contaminated with pharmaceuticals.
    Rizzo L; Meric S; Guida M; Kassinos D; Belgiorno V
    Water Res; 2009 Sep; 43(16):4070-8. PubMed ID: 19596131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
    Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
    Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceuticals in settleable particulate material in urban and non-urban waters.
    Lahti M; Oikari A
    Chemosphere; 2011 Oct; 85(5):826-31. PubMed ID: 21774960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio.
    Spongberg AL; Witter JD
    Sci Total Environ; 2008 Jul; 397(1-3):148-57. PubMed ID: 18396321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantiomeric fraction as an indicator of pharmaceutical biotransformation during wastewater treatment and in the environment--a review.
    Hashim NH; Shafie S; Khan SJ
    Environ Technol; 2010 Nov; 31(12):1349-70. PubMed ID: 21121459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of pharmaceuticals in contaminated urban wastewater effluent under ultrasonic irradiation.
    Naddeo V; Meriç S; Kassinos D; Belgiorno V; Guida M
    Water Res; 2009 Sep; 43(16):4019-27. PubMed ID: 19589554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia.
    Gracia-Lor E; Sancho JV; Serrano R; Hernández F
    Chemosphere; 2012 Apr; 87(5):453-62. PubMed ID: 22221664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy.
    Al Aukidy M; Verlicchi P; Jelic A; Petrovic M; Barcelò D
    Sci Total Environ; 2012 Nov; 438():15-25. PubMed ID: 22967493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and reduction of pharmaceuticals in the water phase at Swedish wastewater treatment plants.
    Falås P; Andersen HR; Ledin A; la Cour Jansen J
    Water Sci Technol; 2012; 66(4):783-91. PubMed ID: 22766867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
    Verlicchi P; Al Aukidy M; Galletti A; Petrovic M; Barceló D
    Sci Total Environ; 2012 Jul; 430():109-18. PubMed ID: 22634557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contamination profiles and mass loadings of macrolide antibiotics and illicit drugs from a small urban wastewater treatment plant.
    Loganathan B; Phillips M; Mowery H; Jones-Lepp TL
    Chemosphere; 2009 Mar; 75(1):70-7. PubMed ID: 19121838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceuticals and other organic chemicals in selected north-central and northwestern Arkansas streams.
    Haggard BE; Galloway JM; Green WR; Meyer MT
    J Environ Qual; 2006; 35(4):1078-87. PubMed ID: 16738393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics and attenuation of acidic pharmaceuticals along a river stretch.
    Radke M; Ulrich H; Wurm C; Kunkel U
    Environ Sci Technol; 2010 Apr; 44(8):2968-74. PubMed ID: 20235612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluoroalkyl sulfonates and perfluorocarboxylates in two wastewater treatment facilities in Kentucky and Georgia.
    Loganathan BG; Sajwan KS; Sinclair E; Senthil Kumar K; Kannan K
    Water Res; 2007 Dec; 41(20):4611-20. PubMed ID: 17632203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.